The organisation of cancer services is informed by the recommendations contained in a number of reports, including the national cancer strategy 1996 and the report of the sub-group of the National Cancer Forum on the development of services for symptomatic breast disease. The essential organisation requirements are based on the provision of care in a multi-disciplinary team setting, adequate patient numbers and access to technology to ensure adherence to international standards of best practice and quality assurance.
In order to support the achievement of these objectives, over €103 million has been invested in the development of appropriate treatment and care services for people with cancer. Among a range of other initiatives, this investment has enabled the funding of 76 additional consultant posts in key areas such as medical oncology, radiology, symptomatic breast disease, palliative care, histopathology and haematology, together with support staff. This year a total of €27.3 million was provided for the maintenance and development of cancer services. This includes the provision of €23.55 million which was allocated between all health boards for the continuing development of oncology services, including funding for oncology drug treatments.